The External Quality Assurance Program Oversight Laboratory (EQAPOL) is a National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)-Division of AIDS (DAIDS) funded resource located at Duke Human Vaccine Institute's (DHVI) Immunology and Virology Quality Assessment Center (IVQAC);to support the development, implementation and oversight of external quality assurance programs that monitor laboratories involved in HIV/AIDS research and vaccine trials around the world.

The EQAPOL Program consists of the following components:

  • Maintain a Peripheral Blood Mononuclear Cell (PBMC) Cell Bank and Reagent Repository
  • An Enzyme-linked Immunosorbent Spot (ELISpot) Assay External Quality Assurance (EQA) Program
  • An EQA Program for Flow Cytometry-based Assays
  • Establish and Characterize Unique Clade-Specific HIV Virus Panels
  • A Luminex EQA Program
  • Validate an A3R5 Neutralization Assay and administer an EQA Program
  • A Limiting Antigen (LAg) Avidity Incidence Assay EQA Program
  • Create a Central Web Database for the Above Activities